$25.6274
0[0.00%]
At close: Apr 23
Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC), Analyst Ratings, Price Targets, Predictions
Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Analyst Ratings for Virtus LifeSci Biotech Clinical Trials ETF
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?
There is no price target for Virtus LifeSci Biotech Clinical Trials ETF.
What is the most recent analyst rating for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?
There is no analyst for Virtus LifeSci Biotech Clinical Trials ETF.
When was the last upgrade for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?
There is no last upgrade for Virtus LifeSci Biotech Clinical Trials ETF.
When was the last downgrade for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?
There is no last downgrade for Virtus LifeSci Biotech Clinical Trials ETF.
When is the next analyst rating going to be posted or updated for Virtus LifeSci Biotech Clinical Trials ETF (BBC)?
There is no next analyst rating for Virtus LifeSci Biotech Clinical Trials ETF.
Is the Analyst Rating Virtus LifeSci Biotech Clinical Trials ETF (BBC) correct?
There is no next analyst rating for Virtus LifeSci Biotech Clinical Trials ETF.
Browse analyst ratings and price targets on all stocks.